Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

NCT04542694 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Favipiravir
DRUG: Standard of care

Sponsor

Promomed, LLC